Short Interest in Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Expands By 91.7%

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 65,000 shares, a growth of 91.7% from the January 15th total of 33,900 shares. Based on an average daily volume of 471,700 shares, the days-to-cover ratio is currently 0.1 days.

Daiichi Sankyo Stock Down 2.3 %

Daiichi Sankyo stock traded down $0.56 during trading hours on Friday, hitting $23.89. The stock had a trading volume of 199,873 shares, compared to its average volume of 213,522. The stock has a market cap of $45.59 billion and a price-to-earnings ratio of 26.73. Daiichi Sankyo has a one year low of $22.80 and a one year high of $42.48. The business’s 50 day simple moving average is $27.21 and its 200-day simple moving average is $32.11.

Daiichi Sankyo (OTCMKTS:DSNKY) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.22 earnings per share (EPS) for the quarter. Research analysts anticipate that Daiichi Sankyo will post 0.82 EPS for the current fiscal year.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.